

Free BAC Waterwith every order5-Amino-1MQ
₡40,069. The bigger discount applies; not combined with volume pricing.
Frequently ordered together
₡40,069
Specifications
Questions
The compound and amount on the label, as lyophilized powder (or ready-to-use liquid for blends and waters). Most products have a Certificate of Analysis confirming identity and purity.
2–4 business days anywhere in Costa Rica, tracked, from our own cold storage. No customs or import fees.
Card, SINPE Móvil or bank transfer.
15% off 5+ vials of the same product, 20% off 10+. The best discount applies automatically. Every order includes a free BAC Water 3 ml, and delivery is free over ₡89,043.
No. All products are for laboratory research use only. We don't provide dosing or medical advice.
Why order from us
What people say
★★★★★Excellent service, quality, and price. For me, they are the best in Costa Rica; I hope they never change.
★★★★★Hay stock y son rápidos y asesoran muy bien, confiable los pagos y el producto llega en buen estado.
★★★★★Son excelentes, mil estrellas.
More in Metabolic & GLP-1
Research use only. Supplied for laboratory research. Not for human or veterinary use. We do not provide dosing or medical advice.
Studies
What 5-Amino-1MQ Is and What the Studies Measured Compound Class and Identity 5-Amino-1MQ is not a peptide. It is 5-amino-1-methylquinolinium, a small-molecule quinolinium salt, supplied most commonly as the iodide. The cation is C10H11N2 with a molecular weight of 159.21. As the iodide salt the formula is C10H11N2·I at 286.11, and as the chloride it is 194.66. CAS 42464-96-0 is assigned to the iodide. Salt form is stated on the batch certificate. What the Primary Study Reported The principal published work is Neelakantan and colleagues, Biochemical Pharmacology, 2018. The model was male C57BL/6 mice with diet-induced obesity, given the compound systemically. Reported measurements were body weight, white adipose mass, adipocyte size, epididymal fat-pad weight, plasma total cholesterol, and tissue NAD+, SAM and 1-methylnicotinamide. Those are the endpoints the paper measured, in that species, under that diet. The Enzyme Target Nicotinamide N-methyltransferase transfers a methyl group from S-adenosylmethionine to nicotinamide, producing 1-methylnicotinamide and consuming SAM. Nicotinamide is a precursor in the salvage route to NAD+, so NNMT activity sits at a junction between methyl-group supply and NAD+ availability. 5-Amino-1MQ binds at the substrate site rather than the cofactor site, which is the basis of its reported selectivity. Where the Evidence Stops The published record on 5-Amino-1MQ is preclinical. Work exists in rodent models of diet-induced obesity, in muscle injury models and in ovarian cancer models, alongside cell-culture work in adipocytes. No human clinical trial results have been published for this compound. There is no published human pharmacokinetic data, no established safety profile in people, and no regulatory submission anywhere. That is the whole picture.
Why Choose Peptides Costa Rica’s 5-Amino-1MQ?
We specialize in supplying high-purity research peptides with a focus on transparency, fast domestic delivery, and dedicated customer support.
5-Amino-1MQ Research Overview
Nicotinamide N-methyltransferase was characterised as a cytosolic methyltransferase long before it became a drug target. Interest grew when expression was found to be elevated in white adipose tissue and liver in several metabolic disease models, and again when the same enzyme was found overexpressed across a range of tumour types.
Small-molecule inhibitors followed. 5-Amino-1MQ emerged from work at the University of Texas Health Science Center at San Antonio and the University of Texas Medical Branch, published by Neelakantan and colleagues. The design goal was a compound that inhibited at the nicotinamide substrate site and crossed cell membranes, since earlier bisubstrate inhibitors were potent but poorly permeable.
The 2018 Biochemical Pharmacology paper tested the compound in male C57BL/6 mice maintained on a high-fat diet, measuring body weight, white adipose mass, adipocyte size and plasma cholesterol alongside tissue NAD+, SAM and 1-methylnicotinamide.
Subsequent preclinical work extended to skeletal muscle injury models and to ovarian cancer metastasis models, where NNMT overexpression is a feature of the disease biology rather than of metabolism.
No human clinical trial results have been published. Research interest is real and continuing; the human evidence base does not yet exist.
Get In Touch
Have questions about 5-Amino-1MQ products or research-use details? Our team can help you review available options, product information, storage guidance, and ordering details.
Why Researchers Choose 5-Amino-1MQ
A defined small molecule with a known enzyme target, documented purity, and stock held locally.
Trusted Source for Research Peptides
We supply high-purity 5-Amino-1MQ and other research peptides with a focus on consistent quality, transparent pricing, and reliable local delivery. Every order ships from inside Costa Rica, so you avoid the customs delays, import duties, and uncertainty that come with international peptide purchases.
How to order
- 1ChoosePick the strength and quantity. Bulk discounts apply automatically.
- 2CheckoutPay by card, or send the order on WhatsApp for SINPE or bank transfer.
- 3ReceiveDelivered in 2–4 days with your batch COA.
5-Amino-1MQ FAQ
5-Amino-1MQ is a small molecule, not a peptide, despite the name it is usually catalogued under. Its chemical name is 5-amino-1-methylquinolin-1-ium, and it is normally supplied as the iodide salt, CAS 42464-96-0, molecular weight 286.11. It inhibits nicotinamide N-methyltransferase by binding at the substrate site. It is supplied as a lyophilised powder in 5mg vials for laboratory use. It contains no amino acids and no peptide bonds, so peptide sequence and peptide purity conventions do not apply to it.
Nicotinamide N-methyltransferase transfers a methyl group from S-adenosylmethionine onto nicotinamide, producing 1-methylnicotinamide. Nicotinamide is a precursor in the salvage pathway to NAD+, so the enzyme sits where methyl-group supply and NAD+ availability meet. 5-Amino-1MQ occupies the nicotinamide substrate site rather than the SAM cofactor site, and it is membrane-permeable. Published measurements of downstream NAD+, SAM and 1-methylnicotinamide come from rodent tissue and cell culture.
5-Amino-1MQ is supplied as a lyophilised powder and should be stored cool and dry. Refrigeration suits short-term storage; freezing is appropriate for long-term storage, and reagent suppliers commonly specify minus twenty degrees Celsius. Vials should remain sealed until use, and the original vial packaging protects against light and moisture. In a laboratory setting, handling requires attention to contamination control and to the fact that the material is non-sterile. Storage and handling affect the integrity of the material; they are not a statement about what it does.
Published work is preclinical. The principal paper tested the compound in male C57BL/6 mice with diet-induced obesity, measuring body weight, white adipose mass, adipocyte size, plasma cholesterol and tissue NAD+, SAM and 1-methylnicotinamide. Further preclinical work covers skeletal muscle injury models and ovarian cancer metastasis models, where NNMT is overexpressed. No human clinical trial results have been published.
They are different classes of compound with different targets. 5-Amino-1MQ is a small-molecule quinolinium salt that inhibits nicotinamide N-methyltransferase at the substrate site. Mots-C is a sixteen-amino-acid peptide encoded in mitochondrial DNA, studied in relation to AMPK signalling and mitochondrial function. One is a synthesised enzyme inhibitor with a defined molecular weight; the other is a peptide with a defined sequence. Both are characterised in preclinical models only.
Orders are typically delivered within 2–4 business days from the date the order is placed. Delivery times may vary depending on the shipping destination, carrier delays, and order processing times.
No. It is a small-molecule quinolinium salt with no amino acids and no peptide bonds. It appears in peptide catalogues because of where researchers buy it, not because of what it is. Purity by HPLC applies to it normally, but identity is confirmed against a molecular weight rather than an amino acid sequence.







